ARCHIVES

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

This article is from The Cancer Letter archive.

Vol. 01 No. 49 | December 5, 1975

Download PDF Visit The Full Archive

Related Articles

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012

NCAB Committee, NCI Split On Starting New Organ Systems Autodigestive Group

February 15, 1985

Obituary: Lee Wattenberg, 92, “Father of Chemoprevention”

December 12, 2014

Sister Study To Examine Risk Factors For Breast Cancer In 50,000 Women

October 29, 2004

Signet Cell A Rising Trend In Patients Under Age 40

November 25, 2011

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013